Cargando…

Safety and efficacy of autologous tumour cell vaccines as a cancer therapeutic to treat solid tumours and haematological malignancies: a meta-analysis protocol for two systematic reviews

INTRODUCTION: Autologous cancer cell vaccines are promising personalised immunotherapeutic options for solid and haematological malignancies that uses the patient’s own cells to arm an immune response. Evidence suggests that among patients receiving these vaccines, those who mount an immune response...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Sarwat T, Montroy, Joshua, Forbes, Nicole, Bastin, Donald, Kennedy, Michael A, Diallo, Jean-Simon, Kekre, Natasha, Fergusson, Dean A, Lalu, Manoj, Auer, Rebecca C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282323/ https://www.ncbi.nlm.nih.gov/pubmed/32518209 http://dx.doi.org/10.1136/bmjopen-2019-034714

Ejemplares similares

Safety and efficacy of autologous cell vaccines in solid tumors: a systematic review and meta-analysis of randomized control trials
por: Bastin, Donald J., et al.
Publicado: (2023)

Efficacy and safety of chimeric antigen receptor T-cell (CAR-T) therapy in patients with haematological and solid malignancies: protocol for a systematic review and meta-analysis
por: Grigor, Emma J M, et al.
Publicado: (2017)

Cancer Chemotherapy—Its role in the Treatment Strategy of Haematologic Malignancies and Solid Tumours
por: Crowther, D.
Publicado: (1977)

Mapping the preclinical to clinical evidence and development trajectory of the oncolytic virus talimogene laherparepvec (T-VEC): a systematic review
por: Lalu, Manoj, et al.
Publicado: (2019)

The use of bisphosphonates in the management of bone involvement from solid tumours and haematological malignancies – a European survey
por: Lebret, T., et al.
Publicado: (2016)

Cytomegalovirus in Haematological Tumours
por: Alonso-Álvarez, Sara, et al.
Publicado: (2021)

Population pharmacokinetics of pevonedistat alone or in combination with standard of care in patients with solid tumours or haematological malignancies
por: Faessel, Hélène M., et al.
Publicado: (2019)

Comparison of epidemiological, clinical and microbiological characteristics of bloodstream infection in children with solid tumours and haematological malignancies
por: Garrido, M. M., et al.
Publicado: (2019)

Hematologists’ barriers and enablers to screening and recruiting patients to a chimeric antigen receptor (CAR) T cell therapy trial: a theory-informed interview study
por: Castillo, Gisell, et al.
Publicado: (2021)

Identifying effect modifiers of CAR-T cell therapeutic efficacy: a systematic review and individual patient data meta-analysis protocol
por: Lalu, Manoj M., et al.
Publicado: (2023)

The effect of anticancer therapy on anti-hepatitis B antibody titres in patients with haematological malignancies and solid tumours
por: Yilmaz, Bahiddin, et al.
Publicado: (2016)

A systematic assessment of preclinical multilaboratory studies and a comparison to single laboratory studies
por: Hunniford, Victoria T, et al.
Publicado: (2023)

Navigating choice in the face of uncertainty: using a theory informed qualitative approach to identifying potential patient barriers and enablers to participating in an early phase chimeric antigen receptor T (CAR-T) cell therapy trial
por: Castillo, Gisell, et al.
Publicado: (2021)

Activity of cyclosporins as resistance modifiers in primary cultures of human haematological and solid tumours.
por: Fridborg, H., et al.
Publicado: (1994)

Epithelial Mesenchymal Transition (EMT) and Associated Invasive Adhesions in Solid and Haematological Tumours
por: Greaves, David, et al.
Publicado: (2022)

Partnering with patients to get better outcomes with chimeric antigen receptor T-cell therapy: towards engagement of patients in early phase trials
por: Foster, Madison, et al.
Publicado: (2020)

Cancer-Associated Thrombosis: A Clinical Scoping Review of the Risk Assessment Models Across Solid Tumours and Haematological Malignancies
por: Mosaad, Manar, et al.
Publicado: (2021)

The effects of resistant starches on inflammatory bowel disease in preclinical and clinical settings: a systematic review and meta-analysis
por: Montroy, Joshua, et al.
Publicado: (2020)

Targeting hypoxia in solid and haematological malignancies
por: Harris, Bill, et al.
Publicado: (2022)

Advances in the application of Raman spectroscopy in haematological tumours
por: Liang, Haoyue, et al.
Publicado: (2023)

Methods and efficacy of extracellular vesicles derived from mesenchymal stromal cells in animal models of disease: a preclinical systematic review protocol
por: Tieu, Alvin, et al.
Publicado: (2019)

Mesenchymal stromal cell extracellular vesicles as therapy for acute and chronic respiratory diseases: A meta‐analysis
por: Tieu, Alvin, et al.
Publicado: (2021)

T Cell Fitness and Autologous CAR T Cell Therapy in Haematologic Malignancy
por: Mehta, Palak H., et al.
Publicado: (2021)

Regenerative cell therapy for pulmonary arterial hypertension in animal models: a systematic review
por: Suen, Colin M., et al.
Publicado: (2019)

Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022
por: Snowden, John A., et al.
Publicado: (2022)

Tumour to Tumour Metastasis of Malignant Melanoma to Intracranial Tumour
por: Shariff, Zakir, et al.
Publicado: (2009)

Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours
por: Nicol, A J, et al.
Publicado: (2011)

Antiviral prophylaxis in patients with solid tumours and haematological malignancies—update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)
por: Sandherr, Michael, et al.
Publicado: (2015)

Cells bearing Fc receptors in human malignant solid tumours.
por: Svennevig, J. L., et al.
Publicado: (1982)

Decreased blood histamine levels in patients with solid malignant tumours.
por: Burtin, C., et al.
Publicado: (1983)

T lymphocytes against solid malignancies: winning ways to defeat tumours
por: Caruana, Ignazio, et al.
Publicado: (2018)

The influence of sample source and cell concentration on the in vitro chemosensitivity of haematological tumours.
por: Bird, M. C., et al.
Publicado: (1986)

SOLID LIVER TUMOURS
Publicado: (1977)

Immunocancerology in Solid Tumours
por: Moore, M.
Publicado: (1978)

Larotrectinib for solid tumours
Publicado: (2022)

Safety and Efficacy of Adeno-Associated Viral Gene Therapy in Patients With Retinal Degeneration: A Systematic Review and Meta-Analysis
por: Sobh, Mohamad, et al.
Publicado: (2023)

Intra-tumoural microvessel density in human solid tumours
por: Hasan, J, et al.
Publicado: (2002)

Challenging tumour immunological techniques that help to track cancer stem cells in malignant melanomas and other solid tumours
por: Kotlan, Beatrix, et al.
Publicado: (2018)

Functional and Biological Role of Endothelial Precursor Cells in Tumour Progression: A New Potential Therapeutic Target in Haematological Malignancies
por: Reale, Antonia, et al.
Publicado: (2016)

Case Report: Peripheral Ulcerative Keratitis in Systemic Solid Tumour Malignancies
por: Foo, Valencia Hui Xian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_run9pva7mkg013f9738cf19jum